My watch list  

Actavis Group hf.

Dalshraun 1
220 Hafnarfjordur

Company Portrait

Actavis is one of the world's leading players in the development, manufacture, and sale of first-class generic pharmaceuticals. Founded in 1956, the Company has led an assertive programme of expansion, making more than 20 acquisitions in the past seven years while maintaining strong organic growth. The Group has approximately 11,000 employees operating in about 40 countries around the globe. Actavis’ headquarters are in Iceland.

Focus: Manufacturer

Industrial Sectors

  • Pharma
More about Actavis
  • News

    Watson Completes Actavis Acquisition

    Watson Pharmaceuticals, Inc. announced that it has completed the acquisition of the Actavis Group for EUR 4.25 billion.  The combination creates the world's third largest generic pharmaceutical company, with anticipated pro forma combined 2012 revenues in excess of $8 billion. Watson funded ... more

    Actavis acquires PharmaPack International

    Actavis Group has acquired 100% of the shares in PharmaPack International B.V. for an undisclosed amount. PharmaPack is based in Zoetermeer, the Netherlands, and is a specialist in packaging pharmaceutical as well as biotechnological products. The company has extensive experience with produ ... more

    Actavis opens new headquarters in Zug, Switzerland

    Actavis Group formally opened its new management offices in Zug, Switzerland. At a press conference to mark the opening of the new headquarters, CEO Claudio Albrecht stated that the generic industry "needs to change." Payors, he said, need modern approaches to cope with exploding health car ... more

  • Companies

    Actavis Deutschland GmbH & Co. KG


Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE